Current
$10.51B
5-Year Average
$17.79B
All-Time High
$24.92B
All-Time Low
$6.66M
Market cap daily chart for Insulet (PODD)
Jun 16, 2021 – Jun 12, 2026 · 1,254 trading days
Market Cap growth chart for Insulet (PODD) from 2007 to 2026
Latest: -48.6%
Market Cap history table for Insulet (PODD) from 2007 to 2026
| 2026 | $10.51B | -48.6% | −$9.92B | ||
| 2025 | $20.43B | +5.9% | +$1.14B | ||
| 2024 | $19.29B | +20.7% | +$3.31B | ||
| 2023 | $15.98B | -22.4% | −$4.60B | ||
| 2022 | $20.58B | +12.8% | +$2.33B | ||
| 2021 | $18.25B | +8.2% | +$1.39B | ||
| 2020 | $16.86B | +58.0% | +$6.19B | ||
| 2019 | $10.67B | +120.4% | +$5.83B | ||
| 2018 | $4.84B | +20.9% | +$836.92M | ||
| 2017 | $4.00B | +85.5% | +$1.85B | ||
| 2016 | $2.16B | +0.5% | +$10.17M | ||
| 2015 | $2.15B | -16.2% | −$415.19M | ||
| 2014 | $2.56B | +27.9% | +$558.45M | ||
| 2013 | $2.00B | +97.0% | +$986.85M | ||
| 2012 | $1.02B | +15.7% | +$137.78M | ||
| 2011 | $879.17M | +43.2% | +$265.25M | ||
| 2010 | $613.92M | +44.6% | +$189.42M | ||
| 2009 | $424.50M | +99.2% | +$211.35M | ||
| 2008 | $213.16M | -45.6% | −$178.69M | ||
| 2007 | $391.84M | — | — |
- 2026$10.51B-48.6%
- 2025$20.43B+5.9%
- 2024$19.29B+20.7%
- 2023$15.98B-22.4%
- 2022$20.58B+12.8%
- 2021$18.25B+8.2%
- 2020$16.86B+58.0%
- 2019$10.67B+120.4%
- 2018$4.84B+20.9%
- 2017$4.00B+85.5%
- 2016$2.16B+0.5%
- 2015$2.15B-16.2%
- 2014$2.56B+27.9%
- 2013$2.00B+97.0%
- 2012$1.02B+15.7%
- 2011$879.17M+43.2%
- 2010$613.92M+44.6%
- 2009$424.50M+99.2%
- 2008$213.16M-45.6%
- 2007$391.84M—
Market Cap values are taken from Insulet's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Insulet (PODD)
According to Insulet's latest reported financial statements, the company's latest reported market cap is $14.73B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2026 reading of Insulet (PODD) market cap is $10.51B – plunged 48.6% year-over-year.
Through 2021–2026 (5 years), Insulet market cap delivered a -10.4% annualised rate; with a net decline across the window.
Between 2022 and 2026, Insulet market cap plunged 48.9%, falling from $20.58B to $10.51B.
The record annual market cap stands at $20.58B, reached in 2022; the historical low of $213.16M was recorded in 2008.
Insulet Market Cap by Year
Insulet Market Cap 2026: $10.51B
2026's market cap for Insulet came in at $10.51B, plunged 48.6% below 2025.
Insulet Market Cap 2025: $20.43B
Insulet posted market cap of $20.43B in 2025, grew 5.9% from 2024.
Insulet Market Cap 2024: $19.29B
In 2024, Insulet reported market cap of $19.29B, grew 20.7% from 2023.
Insulet Market Cap 2023: $15.98B
Insulet market cap in 2023 was $15.98B, declined 22.4% below 2022.
Insulet Market Cap 2022: $20.58B
Insulet market cap in 2022 was $20.58B.
See more financial history for Insulet (PODD).
Sector peers by Market Cap
Healthcare peers of Insulet (PODD), ranked by their latest market cap
| $1.07T | |
| $579.83B | |
| $391.50B | |
| $371.00B | |
| $294.03B | |
| $277.22B | |
| $194.99B | |
| $191.70B |
- $1.07T
- $579.83B
- $391.50B
- $371.00B
- $294.03B
- $277.22B
- $194.99B
- $191.70B
Frequently asked questions
Insulet (PODD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation